查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946960

2026年全球医药微生物检测套组市场报告

Pharma Microbiology Testing Kits Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，医药微生物检测套组市场成长显着，预计将从2025年的72.6亿美元成长到2026年的79.4亿美元，复合年增长率达9.4%。过去几年成长要素包括：药品品质法规日益严格、生物製药产量增加、人们对污染风险的意识提升、疫苗生产规模扩大以及GMP合规要求。

预计未来几年，医药微生物检测套组市场将快速成长，到2030年市场规模将达到119.8亿美元，复合年增长率（CAGR）为10.8%。预测期内的成长要素包括生物製药产品线的扩张、快速检测技术的普及、监管力度的加大、契约製造的扩张以及自动化品管。预测期内的主要趋势包括无菌检测频率的增加、快速微生物检测方法的日益普及、环境监测项目的扩展、对即用型检测套组需求的增长以及微生物检测服务的外包。

感染疾病日益普遍将持续推动药用微生物检测套组市场的扩张。感染疾病是由细菌、病毒、真菌和寄生虫等致病微生物引起的疾病，可透过直接或间接途径在人与人之间传播。全球旅行的增加加速了病原体的跨境传播，导致感染疾病率持续上升。药用微生物检测套组能够准确快速地检测病原体，从而支持感染疾病的诊断，并在及时做出临床决策方面发挥着至关重要的作用。此外，它们还能确保检测的可靠性，并支持有效的治疗策略和集体爆发控制，进而提高检查室效率。例如，根据英国卫生安全局的数据，截至2024年2月，英国的结核病病例数在2023年达到4850例，比2022年报告的4380例增加了10.7% 。感染疾病日益普遍正是推动药用微生物检测套组市场成长的因素之一。

医药微生物检测套组市场的主要企业正致力于采用人工智慧 (AI) 软体等创新技术，以提高效率、增强诊断准确性并简化检查室工作流程。在此背景下，人工智慧软体指的是能够处理和分析复杂诊断数据的高级演算法，以辅助病原体的检测和鑑定。例如，2023 年 5 月，美国医疗设备製造商贝克顿·迪金森公司 (BD) 的「BD Kiestra MRSA 影像应用」获得了美国食品药物管理局(FDA) 的 510(k) 许可。此应用利用人工智慧技术提高了抗药性金黄色葡萄球菌(MRSA) 的诊断准确性。此应用实现了以往耗时费力的培养皿检测流程的自动化。它能够分析 BBL CHROMagar MRSA II 培养基上的细菌生长情况，并快速识别生长不明显的检体，从而加快处理速度并儘早报告阴性结果。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球医药微生物检测套组市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 永续性、气候技术和循环经济
  • 主要趋势
    • 增加灭菌测试的频率
    • 快速微生物检测方法的应用日益广泛
    • 扩大环境监测计划
    • 对即用型检测套组的需求不断增长
    • 微生物检测服务外包

第五章 终端用户产业市场分析

  • 医院和诊断中心
  • 製药公司
  • 合约研究机构
  • 学术研究机构
  • 生技公司

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球医药微生物检测套组市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球医药微生物检测套组市场规模、比较及成长率分析
  • 全球医药微生物检测套组市场表现：规模与成长，2020-2025年
  • 全球医药微生物检测套组市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 耗材、设备
  • 通过考试
  • 内毒素检测、无菌检测、微生物检测、环境监测等检测
  • 最终用户
  • 医院和诊断中心、客製化化验服务提供者、学术研究机构
  • 按类型细分：消耗品
  • 培养基及试剂、检测套组、检体采集容器
  • 按类型细分：设备
  • 培养箱、高压釜和微生物鑑定係统

第十章 区域与国家分析

  • 全球医药微生物检测套组市场：按地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球医药微生物检测套组市场：依国家划分，实际结果及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 医药微生物检测套组市场：竞争格局及市场占有率（2024年）
  • 医药微生物检测套组市场：公司评估矩阵
  • 医药微生物检测套组市场：公司概况
    • F. Hoffmann-La Roche AG
    • Becton Dickinson and Company
    • Abbott Laboratories
    • ThermoFisher Scientific
    • SGS SA

第37章：其他领先和创新企业

  • Toxikon Corp., Pace Analytical Services, Boston Analytics, Charles River Laboratories International, Nelson Laboratories, Siemens healthcare AG, Hologic Inc., Neogen Corporation, Shimadzu Corporation, Merck KGaA, Agilent TechnologiesInc., QIAGEN NV, Bruker Corporation, bioMerieux SA, Lucideon

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年医药微生物检测套组市场：提供新机会的国家
  • 2030年医药微生物检测套组市场：新兴细分市场机会
  • 2030年医药微生物检测套组市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MPMTK01_G26Q1

Pharma microbiology testing kits are used to detect contamination and maintain quality standards. They help assess microbial limits in drugs, vaccines, and other biological products.

The primary products in pharma microbiology testing kits include consumables and equipment. Consumables used in pharma microbiology testing kits are designed to identify microbial limits in pharmaceuticals, vaccines, and other biological products. The tests conducted using these kits include endotoxin testing, sterility testing, microbial analysis, environmental monitoring, and others, and they are used by end users such as hospitals and diagnostic centers, contract laboratory service providers, and academic and research institutions.

Tariffs are impacting the pharma microbiology testing kits market by increasing costs of imported consumables, reagents, and laboratory equipment, particularly in north america and europe. Consumables and microbial identification equipment segments are most impacted. On the positive side, tariffs are encouraging local reagent manufacturing and strengthening regional supply chains.

The pharma microbiology testing kits market research report is one of a series of new reports from The Business Research Company that provides pharma microbiology testing kits market statistics, including pharma microbiology testing kits industry global market size, regional shares, competitors with a pharma microbiology testing kits market share, detailed pharma microbiology testing kits market segments, market trends and opportunities, and any further data you may need to thrive in the pharma microbiology testing kits industry. This pharma microbiology testing kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharma microbiology testing kits market size has grown strongly in recent years. It will grow from $7.26 billion in 2025 to $7.94 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to pharmaceutical quality regulations, biologics production growth, contamination risk awareness, vaccine manufacturing expansion, gmp compliance requirements.

The pharma microbiology testing kits market size is expected to see rapid growth in the next few years. It will grow to $11.98 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to biopharmaceutical pipeline growth, rapid testing technology adoption, regulatory stringency increase, contract manufacturing expansion, automation in quality control. Major trends in the forecast period include increased sterility testing frequency, rising adoption of rapid microbial detection, expansion of environmental monitoring programs, higher demand for ready-to-use test kits, outsourcing of microbiology testing services.

The growing prevalence of infectious diseases is increasingly supporting the expansion of the pharma microbiology testing kits market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites, which can spread directly or indirectly between individuals. The incidence of infectious diseases continues to rise due to increased global travel, which accelerates the cross-border transmission of pathogens. Pharma microbiology testing kits support infectious disease diagnosis by enabling accurate and rapid pathogen detection, making them essential for timely clinical decision-making. These kits also enhance laboratory efficiency by ensuring reliable testing and supporting effective treatment strategies and outbreak control. For example, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis cases in England increased to 4,850 in 2023, representing a 10.7% rise from 4,380 cases reported in 2022. As a result, the rising prevalence of infectious diseases is contributing to the expansion of the pharma microbiology testing kits market.

Leading companies operating in the pharma microbiology testing kits market are focusing on adopting innovative technologies, such as artificial intelligence-powered software, to improve efficiency, enhance diagnostic accuracy, and streamline laboratory workflows. Artificial intelligence-powered software in this context refers to advanced algorithms that process and analyze complex diagnostic data to support the detection and identification of pathogens. For example, in May 2023, Becton, Dickinson, and Company, a US-based medical device company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its BD Kiestra MRSA Imaging Application, which uses artificial intelligence to improve the diagnosis of methicillin-resistant Staphylococcus aureus (MRSA). The application automates the inspection of Petri dishes, a process that is traditionally labor-intensive and time-consuming. It analyzes bacterial growth on BBL CHROMagar MRSA II plates and rapidly identifies specimens with no significant growth, enabling faster processing and quicker release of negative results.

In September 2024, Eurofins Scientific Inc., a Luxembourg-based biopharmaceutical product testing company, acquired Infinity Laboratories Inc. for an undisclosed amount. Through this acquisition, Eurofins seeks to expand its pharmaceutical microbiology testing capabilities, strengthen its footprint in North America, and enhance its portfolio of high-quality analytical and regulatory testing services supporting drug development and manufacturing. Infinity Laboratories Inc. is a US-based pharmaceutical microbiology testing company providing bioburden, sterility, endotoxin, and other microbiological assays for drug development and quality assurance.

Major companies operating in the pharma microbiology testing kits market are F. Hoffmann-La Roche AG, Becton Dickinson and Company, Abbott Laboratories, ThermoFisher Scientific, SGS SA, Toxikon Corp., Pace Analytical Services, Boston Analytics, Charles River Laboratories International, Nelson Laboratories, Siemens healthcare AG, Hologic Inc., Neogen Corporation, Shimadzu Corporation, Merck KGaA, Agilent TechnologiesInc., QIAGEN N.V., Bruker Corporation, bioMerieux SA, Lucideon, Lonza Group AG, MilliporeSigma, Hardy Diagnostics, Sartorius AG, 3M Company, Waters Corporation, PerkinElmer Inc., Luminex Corporation

North America was the largest region in the pharma microbiology testing kits market in 2025. Western Europe was the second-largest region in the global pharma microbiology testing kits market report. The regions covered in the pharma microbiology testing kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharma microbiology testing kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pharma microbiology testing kits market consists of sales of rapid test systems, common rapid test kits, rapid tests for salmonella, PCR test, and lateral flow. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharma Microbiology Testing Kits Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharma microbiology testing kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharma microbiology testing kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharma microbiology testing kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Consumables; Equipment
  • 2) By Test: Endotoxin Testing; Sterility Testing; Microbial Examination; Environmental Monitoring; Other Tests
  • 3) By End User: Hospitals And Diagnostic Centers; Custom Lab Service Providers; Academic And Research Institutes
  • Subsegments:
  • 1) By Consumables: Media and Reagents; Test Kits; Sample Collection Containers
  • 2) By Equipment: Incubators; Autoclaves; Microbial Identification Systems
  • Companies Mentioned: F. Hoffmann-La Roche AG; Becton Dickinson and Company; Abbott Laboratories; ThermoFisher Scientific; SGS SA; Toxikon Corp.; Pace Analytical Services; Boston Analytics; Charles River Laboratories International; Nelson Laboratories; Siemens healthcare AG; Hologic Inc.; Neogen Corporation; Shimadzu Corporation; Merck KGaA; Agilent TechnologiesInc.; QIAGEN N.V.; Bruker Corporation; bioMerieux SA; Lucideon; Lonza Group AG; MilliporeSigma; Hardy Diagnostics; Sartorius AG; 3M Company; Waters Corporation; PerkinElmer Inc.; Luminex Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Pharma Microbiology Testing Kits Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Pharma Microbiology Testing Kits Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Pharma Microbiology Testing Kits Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Pharma Microbiology Testing Kits Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Increased Sterility Testing Frequency
    • 4.2.2 Rising Adoption Of Rapid Microbial Detection
    • 4.2.3 Expansion Of Environmental Monitoring Programs
    • 4.2.4 Higher Demand For Ready-To-Use Test Kits
    • 4.2.5 Outsourcing Of Microbiology Testing Services

5. Pharma Microbiology Testing Kits Market Analysis Of End Use Industries

  • 5.1 Hospitals And Diagnostic Centers
  • 5.2 Pharmaceutical Manufacturers
  • 5.3 Contract Research Organizations
  • 5.4 Academic And Research Institutes
  • 5.5 Biotechnology Companies

6. Pharma Microbiology Testing Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharma Microbiology Testing Kits Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Pharma Microbiology Testing Kits PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Pharma Microbiology Testing Kits Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Pharma Microbiology Testing Kits Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Pharma Microbiology Testing Kits Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharma Microbiology Testing Kits Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharma Microbiology Testing Kits Market Segmentation

  • 9.1. Global Pharma Microbiology Testing Kits Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consumables, Equipment
  • 9.2. Global Pharma Microbiology Testing Kits Market, Segmentation By Test, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Endotoxin Testing, Sterility Testing, Microbial Examination, Environmental Monitoring, Other Tests
  • 9.3. Global Pharma Microbiology Testing Kits Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Diagnostic Centers, Custom Lab Service Providers, Academic And Research Institutes
  • 9.4. Global Pharma Microbiology Testing Kits Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Media and Reagents, Test Kits, Sample Collection Containers
  • 9.5. Global Pharma Microbiology Testing Kits Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Incubators, Autoclaves, Microbial Identification Systems

10. Pharma Microbiology Testing Kits Market Regional And Country Analysis

  • 10.1. Global Pharma Microbiology Testing Kits Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Pharma Microbiology Testing Kits Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharma Microbiology Testing Kits Market

  • 11.1. Asia-Pacific Pharma Microbiology Testing Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharma Microbiology Testing Kits Market

  • 12.1. China Pharma Microbiology Testing Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharma Microbiology Testing Kits Market

  • 13.1. India Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharma Microbiology Testing Kits Market

  • 14.1. Japan Pharma Microbiology Testing Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharma Microbiology Testing Kits Market

  • 15.1. Australia Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharma Microbiology Testing Kits Market

  • 16.1. Indonesia Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharma Microbiology Testing Kits Market

  • 17.1. South Korea Pharma Microbiology Testing Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharma Microbiology Testing Kits Market

  • 18.1. Taiwan Pharma Microbiology Testing Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharma Microbiology Testing Kits Market

  • 19.1. South East Asia Pharma Microbiology Testing Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharma Microbiology Testing Kits Market

  • 20.1. Western Europe Pharma Microbiology Testing Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharma Microbiology Testing Kits Market

  • 21.1. UK Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharma Microbiology Testing Kits Market

  • 22.1. Germany Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharma Microbiology Testing Kits Market

  • 23.1. France Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharma Microbiology Testing Kits Market

  • 24.1. Italy Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharma Microbiology Testing Kits Market

  • 25.1. Spain Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharma Microbiology Testing Kits Market

  • 26.1. Eastern Europe Pharma Microbiology Testing Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharma Microbiology Testing Kits Market

  • 27.1. Russia Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharma Microbiology Testing Kits Market

  • 28.1. North America Pharma Microbiology Testing Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharma Microbiology Testing Kits Market

  • 29.1. USA Pharma Microbiology Testing Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharma Microbiology Testing Kits Market

  • 30.1. Canada Pharma Microbiology Testing Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharma Microbiology Testing Kits Market

  • 31.1. South America Pharma Microbiology Testing Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharma Microbiology Testing Kits Market

  • 32.1. Brazil Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharma Microbiology Testing Kits Market

  • 33.1. Middle East Pharma Microbiology Testing Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharma Microbiology Testing Kits Market

  • 34.1. Africa Pharma Microbiology Testing Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Pharma Microbiology Testing Kits Market, Segmentation By Product, Segmentation By Test, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharma Microbiology Testing Kits Market Regulatory and Investment Landscape

36. Pharma Microbiology Testing Kits Market Competitive Landscape And Company Profiles

  • 36.1. Pharma Microbiology Testing Kits Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Pharma Microbiology Testing Kits Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Pharma Microbiology Testing Kits Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. ThermoFisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. SGS SA Overview, Products and Services, Strategy and Financial Analysis

37. Pharma Microbiology Testing Kits Market Other Major And Innovative Companies

  • Toxikon Corp., Pace Analytical Services, Boston Analytics, Charles River Laboratories International, Nelson Laboratories, Siemens healthcare AG, Hologic Inc., Neogen Corporation, Shimadzu Corporation, Merck KGaA, Agilent TechnologiesInc., QIAGEN N.V., Bruker Corporation, bioMerieux SA, Lucideon

38. Global Pharma Microbiology Testing Kits Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharma Microbiology Testing Kits Market

40. Pharma Microbiology Testing Kits Market High Potential Countries, Segments and Strategies

  • 40.1 Pharma Microbiology Testing Kits Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Pharma Microbiology Testing Kits Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Pharma Microbiology Testing Kits Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer